Results 1 - 20 of 167 for All Library Resources
Sorted by:
Sorted by:
Date-oldestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Newspaper Article
|
|
IDM Pharma Receives Special Protocol Assessment from FDA for Phase 2/3 Trial of Bexidem for Superficial Bladder CancerBusiness Wire, 2006-06-13COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 2 |
Material Type: Newspaper Article
|
|
Schering AG and Biogen Idec Announce Start of the ZEAL Phase III Clinical Trial With Anti-Cancer Drug Zevalin(R)Business Wire, 2006-10-05COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 3 |
Material Type: Newspaper Article
|
|
IDM Pharma Submits New Drug Application to the FDA for Junovan(TM) (mifamurtide) in the Treatment of OsteosarcomaBusiness Wire, 2006-10-26COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 4 |
Material Type: Newspaper Article
|
|
Synta Pharmaceuticals Announces FDA Fast Track Designation for STA-4783 in Metastatic MelanomaBusiness Wire, 2006-11-15COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 5 |
Material Type: Newspaper Article
|
|
Geron Initiates Clinical Trial of Telomerase Inhibitor Drug in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung CancerBusiness Wire, 2007-07-09COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 6 |
Material Type: Newspaper Article
|
|
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety ReviewBusiness Wire, 2007-07-12COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 7 |
Material Type: Newspaper Article
|
|
Inovio Biomedical Partner Tripep Receives Approval to Initiate Phase I/II Study of Novel Vaccine for Hepatitis C VirusBusiness Wire, 2007-08-16COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 8 |
Material Type: Newspaper Article
|
|
GTx's Toremifene Citrate 80 mg Meets Primary and Key Endpoints in Phase III Trial in Advanced Prostate Cancer Patients on Androgen Deprivation TherapyBusiness Wire, 2008-02-25COPYRIGHT 2008 Business Wire, Inc.Digital Resources/Online E-Resources |
| 9 |
Material Type: Newspaper Article
|
|
Ipsen: Toremifene Citrate 80 mg Meets Primary and Key Secondary Endpoints in Phase III Clinical Trial in Advanced Prostate Cancer Patients on Androgen Deprivation TherapyBusiness Wire, 2008-02-25COPYRIGHT 2008 Business Wire, Inc.Digital Resources/Online E-Resources |
| 10 |
Material Type: Newspaper Article
|
|
Ichor Melanoma Vaccine Clinical Trial Moves to Highest Dose LevelBusiness Wire, 2008-03-04COPYRIGHT 2008 Business Wire, Inc.Digital Resources/Online E-Resources |
| 11 |
Material Type: Newspaper Article
|
|
Phase III Data on BEMA(TM) Fentanyl to be Presented at the American Society of Clinical Oncology (ASCO) Annual MeetingBusiness Wire, 2008-05-30COPYRIGHT 2008 Business Wire, Inc.Digital Resources/Online E-Resources |
| 12 |
Material Type: Newspaper Article
|
|
ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung CancerBusiness Wire, 2008-05-31COPYRIGHT 2008 Business Wire, Inc.Digital Resources/Online E-Resources |
| 13 |
Material Type: Newspaper Article
|
|
Molecular Insight Pharmaceuticals, Inc. Reports Preclinical Data on Solazed(TM) for Treatment of Metastatic Melanoma at Society of Nuclear Medicine (SNM) MeetingBusiness Wire, 2008-06-16COPYRIGHT 2008 Business Wire, Inc.Digital Resources/Online E-Resources |
| 14 |
Material Type: Newspaper Article
|
|
GTx Announces Phase III Clinical Development of Toremifene 20 mg on Course Following Planned Safety ReviewBusiness Wire, 2008-07-28COPYRIGHT 2008 Business Wire, Inc.Digital Resources/Online E-Resources |
| 15 |
Material Type: Newspaper Article
|
|
Hollis-Eden Pharmaceuticals Commences Phase I/II Clinical Trial with APOPTONE(TM) (HE3235) in Late-Stage Prostate Cancer PatientsBusiness Wire, 2008-07-30COPYRIGHT 2008 Business Wire, Inc.Digital Resources/Online E-Resources |
| 16 |
Material Type: Newspaper Article
|
|
Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced MelanomaBusiness Wire, 2008-10-06COPYRIGHT 2008 Business Wire, Inc.Digital Resources/Online E-Resources |
| 17 |
Material Type: Newspaper Article
|
|
GTx Announces Investigational Ostarine(TM) (MK-2866) Met the Primary Endpoint in the Phase II Cancer Cachexia Clinical TrialBusiness Wire, 2008-10-13COPYRIGHT 2008 Business Wire, Inc.Digital Resources/Online E-Resources |
| 18 |
Material Type: Newspaper Article
|
|
Synta Announces Continuation of the SYMMETRYSM Trial Based on Evaluation of Independent Data Monitoring CommitteeBusiness Wire, 2008-12-18COPYRIGHT 2008 Business Wire, Inc.Digital Resources/Online E-Resources |
| 19 |
Material Type: Newspaper Article
|
|
Results from a Phase 2 Study of ABRAXANE® In Combination With Carboplatin Show Clinical Activity in the First Line Treatment of Patients with Advanced Non-Small Cell Lung CancerBusiness Wire, 2009-08-03COPYRIGHT 2009 Business Wire, Inc.Digital Resources/Online E-Resources |
| 20 |
Material Type: Newspaper Article
|
|
CytRx Announces Plan to Initiate a Phase 2 Clinical Trial with INNO-206 as a Treatment for Advanced Pancreatic CancerBusiness Wire, 2010-01-06COPYRIGHT 2010 Business Wire, Inc.Digital Resources/Online E-Resources |
Results 1 - 20 of 167 for All Library Resources
Sorted by:
Sorted by:
Date-oldestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Refine My Results
Creation Date
- Before 2009 (19)
- 2009 To 2012 (44)
- 2013 To 2016 (24)
- 2017 To 2021 (46)
- After 2021 (35)
-
More options
New Records
Subject
- Pharmaceutical Industry (118)
- Clinical Trials (101)
- Care And Treatment (97)
- Chemotherapy (53)
- Patient Outcomes (29)
- Metastasis (29)
- Antineoplastic Agents (28)
- Biotechnology Industry (27)
- Drug Therapy (27)
- Oncology, Experimental (27)
- Immunotherapy (26)
- Antimitotic Agents (26)
- Lung Cancer, Non-Small Cell (25)
- Biological Products Industry (20)
- Lung Cancer, Small Cell (18)
- Medical Research (15)
- Medicine, Experimental (14)
- Health Aspects (12)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||